 |
Oramed Pharmaceuticals
to Present Oral Insulin Trial Results at ADA
Conference (June 6-10, San Francisco) (Wed, June 4) |
|
Israel’s
Prestigious President’s Conference to Feature Oramed
Pharmaceuticals’ Revolutionary Oral Insulin Capsule
(Tues,
May 6) |
|
Oramed Pharmaceuticals Partners with OnQ Consulting for Phase 2B Trials on Its Oral Insulin Capsules
Business Wire (Thurs,
Apr 17) |
|
Oramed Pharmaceuticals Commences Phase 2A Clinical Trials in Israel
Business Wire (Tues,
Apr 14) |
|
Oramed Pharmaceuticals Granted Approval to Conduct Phase 2A Trials of Its Oral Insulin Capsule
Business Wire (Tues,
Mar 18) |
|
Oramed Pharmaceuticals Successfully Completes Phase 1B Clinical Trials of Oral Insulin Capsule
Business Wire (Tues,
Mar 11) |
|
Oramed Pharmaceuticals Teams up with OnQ Consulting
Business Wire (Wed,
Jan 30) |
|
Oramed Pharmaceuticals Commences Phase 1B
Clinical Trials
Business Wire (Tues, Jan 22) |
|
Insulin News That's Easy To Swallow
Business Wire (Tues, Jan 17) |
|
Oramed
Pharmaceuticals Successfully
Completes Animal Studies
for Phase 1B Clinical Trials
Of Its Oral Insulin Capsule
Business
Wire (Thu,
Nov 15) |
|
Oramed's CEO to
Present at Rodman & Renshaw's Ninth Annual Healthcare Conference
On November 6, 2007
Business Wire (Fri, Nov 2) |
|
Oramed Pharmaceuticals Successfully Completes Phase 1A Trials
PR Newswire (Tue, Aug 14) |
|
Oramed Pharmaceuticals Completes $2 million in Financing
Business Wire (Mon, Aug 6) |
|
Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials
PrimeNewswire - 05/08/07 |
|
Shazamstocks.com Announces Profile Launch of Oramed Pharmaceuticals, Inc.
PrimeNewswire - 05/03/07 |
|
Oramed Pharmaceuticals Expands Product Line With the Addition of Two New Provisional Patents in the Intellectual Property Portfolio
PrimeNewswire - 05/01/07 |
|
Exclusive Interview With Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.Wallst.Net
PR Newswire - 04/18/07 |
|
AllPennyStocks.com Releases a Special Report On Oramed Pharmaceuticals Inc.
PrimeNewswire - 04/11/07 |
|
Oramed Pharmaceuticals Begins Additions to an Advisory Board
PR Newswire - 04/10/07 |
|
Oramed Pharmaceuticals Rated 'Speculative Buy,' Target Price $1.20 by Beacon Equity Research
BusinessWire - 03/21/07 |
|
"Oramed Pharmaceuticals Announces Maiden Year Progress Report "
PR Newswire - 03/13/07 |
|
"Oramed Pharmaceuticals Announces the Completion of its World Renowned Scientific Board"
PR Newswire - 02/22/07 |
|
"Oramed Pharmaceuticals Inc. Adds Another Accomplished Member to Its Scientific Board"
PR Newswire - 02/21/07 |
|
"Oramed Pharmaceuticals Announces the Expansion of Its Scientific Board With a Prominent American Figure in Diabetes Research"
PR Newswire - 01/31/06 |
|
"Oramed Further Enhances World Renowned Scientific Board of Directors"
PR Newswire - 01/16/07 |
|
"Oramed Pharmaceutical, Inc. Adds to its Scientific Advisory Board"
PR Newswire - 01/09/2007 |
|
"Oramed Pharmaceuticals Discusses Benefits of Oral Insulin Capsule Versus Insulin Inhaler"
PR Newswire - 12/14/06 |
|
"Companies Present at Yale Club in New York City -- EQUITIES Announces Discovery Day Conference XIII"
Market Wire 11/27/06 |
|
"Oramed Pharmaceuticals Signs Manufacturing Agreement for Oral Insulin Pill"
PR Newswire - 11/02/06 |
|
"Oramed Pharmaceuticals Technology Patented with WIPO"
PR Newswire - 09/13/06 |
|
"Oramed Pharmaceuticals Obtains Dual Listing on Frankfurt Stock Exchange"
PRNewswire - 08/02/06 |
|
"Oramed Pharmaceuticals Receives MOH and IRB Approval to Begin Phase 1 Human Trials for
Oral Insulin"
MARKET WIRE - 07/11/06 |
|
"Oral Insulin Pill Could Bring Relief to Millions"
Syndicated News - 06/20/06 |
|
"Exciting Growth Companies to Present at EQUITIES Summer Conference 2006 on June 16, at
the Yale Club in NYC"
MARKET WIRE - 06/13/06 |
|
"Oramed Pharmaceuticals combats diabetes with oral insuli"
Oramed Pharmaceuticals - 06/12/06 |
|
"Integrated Security Technologies Complete Acquisition of Oral Insulin Patent Application "
Integrated Security Technologies, Inc. - 03/13/06 |
|
"Insulin pill offers hope for diabetes"
The Jerusalem Post - 07/05/05 |
Breakthrough medical technology is leading to a
